Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...

Prilenia Therapeutics is planning to file its Huntington’s disease therapy pridopidine in the EU, despite mixed results in a phase 3 trial. Pridopidine is an oral agonist of the S1R protein ...

The robotaxi now operates in more parts of the San Francisco Bay Area and Los Angeles County, and will resume testing in New York City. Abrar's interests include phones, streaming, autonomous ...

The 2025 Open Championship is shaping up to be one of the greatest ever as Grand Slam hero Rory McIlroy returns to Royal Portrush. McIlroy secured his place in golfing history in April by finally ...